The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
“(Friday’s) decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...
People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...
GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...
Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...
As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...
Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...